BiotechTube
Home/Valneva/Peter Bühler
PB

Peter Bühler

Chief Financial Officer

Valneva

Roles

Chief Financial OfficeratValneva
Chief Financial OfficeratValneva SE

Therapeutic Areas

Infectious DiseasesTravel Health

Valneva Pipeline

DrugIndicationPhase
VLA15Lyme DiseasePhase 3
IXCHIQ (VLA1553)ChikungunyaMarketed
Shigella Vaccine CandidateShigellosisPhase 2
Zika Vaccine CandidateZika VirusPhase 2

Leadership Team at Valneva

TL
Thomas Lingelbach
Chief Executive Officer
JC
Juan Carlos Jaramillo, M.D.
Chief Medical Officer
FG
Franck Grimaud
Chief Business Officer
FJ
Frédéric Jacotot
Chief Technical Operations Officer
J(
James (Jim) F. Cummings
General Counsel
View full Valneva profile